Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
258 participants
INTERVENTIONAL
2008-10-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Standard NRT user direction
Nicotine replacement therapy
Nicotine replacement therapy with Standard NRT user direction
2
Novel NRT user direction
Nicotine replacement therapy
Nicotine replacement therapy with a Novel NRT user direction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicotine replacement therapy
Nicotine replacement therapy with Standard NRT user direction
Nicotine replacement therapy
Nicotine replacement therapy with a Novel NRT user direction
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* female participants of child-bearing potential should use a medically acceptable means of birth control
* evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study and consents to participate
Exclusion Criteria
* pregnancy, lactation or intended pregnancy (non-pregnancy will be verified by urine pregnancy test for female participants of child-bearing potential)
* participation in other clinical trials within the previous three months and during study participation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McNeil AB
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elisabeth Kruse, PhD
Role: STUDY_DIRECTOR
Global Medical Affairs & Clinical Research, McNeil AB, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Primary Care and General Practice, University of Birmingham
Birmingham, , United Kingdom
Tobacco Dependence Research Centre at Barts and The London Queen Mary's School of Medicine and Dentistry
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-002498-11
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
NICTDP2010
Identifier Type: -
Identifier Source: org_study_id